Lucid Diagnostics (LUCD) Cash from Investing Activities (2021 - 2026)
Lucid Diagnostics (LUCD) reported Cash from Investing Activities of -$215000.0 for Q1 2026, down 131.18% on a YoY basis from $689482.8 in Q1 2025, and down 321.57% quarter-over-quarter from -$51000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Lucid Diagnostics has reported Cash from Investing Activities for 6 years, with the latest figure at -$215000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 131.18% year-over-year to -$215000.0; the trailing twelve-month figure through Mar 2026 stood at -$319000.0 (up 54.56% YoY), and the FY2025 full-year result was -$197000.0, up 69.5% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$215000.0, down from -$51000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$14000.0 in Q3 2023, with the low at -$2.4 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$336687.5 across 5 years, with a median of -$120500.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 243500.0% — and 2023, when it jumped 99.38%.
- Lucid Diagnostics' Cash from Investing Activities stood at -$203000.0 in 2022, then climbed by 13.79% to -$175000.0 in 2023, then sank by 48.0% to -$259000.0 in 2024, then soared by 80.31% to -$51000.0 in 2025, then slumped by 321.57% to -$215000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$215000.0 (Q1 2026), -$51000.0 (Q4 2025), and -$28000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Lucid Diagnostics | 135.25 Mn | 107.37 Mn | -325,000.00 | -215,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -215,000.00 |
| Mar 31, 2026 | -215,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -93,000.00 |
| Mar 31, 2025 | -93,000.00 |
| Dec 31, 2024 | -259,000.00 |
| Dec 31, 2024 | -259,000.00 |
| Sep 30, 2024 | -350,000.00 |
| Sep 30, 2024 | -350,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -175,000.00 |
| Dec 31, 2023 | -175,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Sep 30, 2023 | -14,000.00 |